Antibacterial and physical properties of a novel sonochemical-assisted Zn-CuO contact lens nanocoating
- 64 Downloads
This work examined the antibacterial and physical effects of a novel Zn-CuO nanocoating applied on a silicone hydrogel contact lens.
Zn-CuO coating of PureVision balafilcon-A soft contact lenses (Bausch&Lomb, Rochester, NY) was performed by sonochemical deposition using a high-intensity ultrasonic horn. Non-coated PureVision lenses served as a control in all experiments. Adhesion assays for P. aerueginosa and S. epidermidis to the coated lenses were performed to identify the minimal coating concentration which still possessed antibacterial activity. Lens water content, oxygen transfer light transfer, leaching, and electron microscopy studies were performed using this concentration.
Coated lenses showed 3–5 log reductions in adhesion of both species. The lowest tested coating concentration of 0.02 wt% led to a log reduction of 3.25 ± 1.25 of P. aeruginosa CFU/lens (P = 0.007) and a log reduction of 4.37 ± 0.75 of S. epidermidis (p = 0.0007). Using this coating concentration, water content (36%, 33.6%), oxygen transfer (87.22 ± 10.96, 92.18 ± 2.38, × 10−11(cm2/s)(mlO2)/(ml × mmHg)), p = 0.12), and light transfer properties did not differ significantly between the coated and the control contact lenses. In the range of 380–780 nm wavelength, the coated lenses transmitted 96.47 ± 1.52% while the control lenses transmitted 97.36 ± 1.35%. The corresponding values for the range of 300–380 nm wavelength were 79.343 ± 8.754 and 80.169 ± 1.35. Leaching studies for 0.5 mM coated lenses have demonstrated the excellent stability of the coating with the release of only 0.005% of the coating after 1 week of exposure to the test solution.
Sonochemical-assisted nanocoating of contact lenses showed significant and consistent antibacterial activity while preserving the basic properties of a silicone hydrogel contact lens.
KeywordsContact lenses Anti-bacterial agents Cornea Infection
The study was supported by a grant from Rabin medical center and by a grant from the Clair and Amedee Martier Institute for the Study of Blindness and Visual Disorders.
Compliance with ethical standards
Conflict of interest
Ilana Perelshtein and Aharon Gedanken are the inventors of a patent relevant to this study. Yoav Nahum is a paid consultant for Shire Pharmaceuticals Israel and Taro Pharmaceuticals Industries, The other authors declare that they have no financial interest to disclose.
This article does not contain any studies with human participants or animals performed by any of the authors.
- 2.S a I, Tuli SS, Wagoner RC (2006) Fungal keratitis: emerging trends and treatment outcomes. Eye Contact Lens 32:267–271. https://doi.org/10.1097/01.icl.0000249595.27520.2e CrossRefGoogle Scholar
- 12.Henriques M, Sousa C, Lira M et al (2005) Adhesion of Pseudomonas aeruginosa and Staphylococcus epidermidis to silicone-hydrogel contact lenses. Optom Vis Sci 82:446–450. https://doi.org/10.1097/01.opx.0000168585.53845.64 CrossRefGoogle Scholar
- 14.ISO Standard 18369–3:2006. (2006) Contact Lenses – Part 3: Measurement Methods. https://ia601001.us.archive.org/27/items/gov.in.is.iso.18369.3.2006/is.iso.18369.3.2006.pdf. Accessed 11 June 2018
- 15.ISO Standard 18369–4:2006. (2006) Contact Lenses – Part 4: Physicochemical properties of contact lens materials. https://ia800407.us.archive.org/21/items/gov.in.is.iso.18369.4.2006/is.iso.18369.4.2006.pdf Accessed 11 June 2018
- 22.Jones L, Brennan NA, González-Méijome J et al (2013) The TFOS international workshop on contact Lens discomfort: report of the contact lens materials, design, and care subcommittee. Investig Ophthalmol Vis Sci 54. https://doi.org/10.1167/iovs.13-13215